To compare ( @ ) rates of stent thrombosis and major adverse cardiac and cerebrovascular events ( MACCE ; composite of death , myocardial infarction , or stroke ) after @ vs @ months of thienopyridine in patients treated with BMS taking aspirin and ( @ ) treatment duration effect within the combined cohorts of randomized patients treated with DES or BMS as prespecified secondary analyses .